Episurf Medical, a Swedish medical device technology company has established a UK subsidiary, to help with expansion plans
Episurf Medical, established a UK subsidiary, to help with expansion plans
Episurf Medical has developed a 3D-based patient-specific joint resurfacing treatment aimed at providing lasting pain relief and restoring joint mobility.
Rosemary Cunningham Thomas, CEO of Episurf Medical, said: “We have previously announced that a key strategic goal for 2015 is to build a presence in UK.
“This market, treatment of knee pain and cartilage damage, represents a significant opportunity for Episurf.
“In 2014, the UK carried out 100,000 knee replacement operations in 400 hospitals and approximately 190 000 arthroscopic procedures”, commented.
The first surgeries in UK, with Episurf’s 3D treatment, were performed in March 2015 at the Rugby Hospital by Professor Tim Spalding.
Spalding said they, “went exactly to plan, the guide fitted perfectly, allowing minimal necessary exposure.
“The instrumentation created the ideal socket and the implant fitted with a complete match. Beautifully elegant and well engineered.”
Episurf Medical has since established a direct sales team in the UK and will be stepping up its marketing efforts to accelerate product adoption.
Thomas said: “Our technology has significant scope to provide patients and clinicians with an advanced technology solution for knee pain within a cost effective framework.
“By offering an on-demand patient-specific production of an all-inclusive one-time-use surgical kit our treatment doesn’t require hospitals to keep our products or instruments in stock.
“I believe that Episurf’s treatment goes hand in hand with the UK NHS guidelines for improved outcome at reduced costs.”